NCT05337735 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05337735
Title	A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
Recruitment	Suspended
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	M.D. Anderson Cancer Center
Indications	lymphoma cervical cancer peritoneal mesothelioma Advanced Solid Tumor cervical squamous cell carcinoma lung small cell carcinoma malignant pleural mesothelioma cervical adenosquamous carcinoma cervical adenocarcinoma Hodgkin's lymphoma neuroendocrine carcinoma colorectal cancer
Therapies	XmAb20717
Age Groups:	adult \| senior
Covered Countries	USA

NCT05337735
Clinical Trial Detail